Sign In
Buy CNMD
$35.16
+0.0300 (+0.0854%)
At Close: Jun 05, 2026
CONMED Corporation Adds Kim Kelderman to its Board of Directors
04:05pm, Tuesday, 09'th Sep 2025
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September 8, 2025. “My fellow directors and I are de
Here's Why Conmed (CNMD) is a Strong Momentum Stock
10:50am, Thursday, 28'th Aug 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
09:31am, Wednesday, 27'th Aug 2025
CNMD's growth drivers - AirSeal, Buffalo Filter, BioBrace, and Foot & Ankle - are offsetting tariffs and supply risks, making the stock worth retaining.
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
10:41am, Monday, 25'th Aug 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Conmed (CNMD) is a Strong Growth Stock
10:46am, Friday, 22'nd Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Conmed (CNMD) is a Top Momentum Stock for the Long-Term
10:50am, Tuesday, 12'th Aug 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CONMED Corporation Announces Quarterly Cash Dividend
07:00am, Friday, 08'th Aug 2025
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share on August 7, 2025, payable on October 3,
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
10:46am, Tuesday, 05'th Aug 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
02:26pm, Thursday, 31'st Jul 2025
CNMD reports solid second-quarter results, driven by improving sales across both segments.
CONMED Corporation (CNMD) Q2 2025 Earnings Call Transcript
10:48pm, Wednesday, 30'th Jul 2025
CONMED Corporation (NYSE:CNMD ) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants Patrick J. Beyer - President, CEO & Director Todd W.
Compared to Estimates, Conmed (CNMD) Q2 Earnings: A Look at Key Metrics
08:01pm, Wednesday, 30'th Jul 2025
While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to
Conmed (CNMD) Q2 Earnings and Revenues Top Estimates
07:01pm, Wednesday, 30'th Jul 2025
Conmed (CNMD) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $0.98 per share a year ago.
CONMED Corporation Announces Second Quarter 2025 Financial Results
04:05pm, Wednesday, 30'th Jul 2025
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Sales of $342.3 million incre
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
09:20am, Thursday, 10'th Jul 2025
CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Martha Aronson will be stepping down from the company's Board of Directors to assume the role of President and Chief
